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Abstract
Background: Several genes associated with dystonia have been identified. A mutation in one of these, THAP1 (DYT6), is linked to isolated dystonia. The aim of
this study was to assess the prevalence of THAP1 gene mutations and the clinical characteristics of patients with these mutations in a clinical population in Brazil.
Methods: Seventy-four patients presenting with dystonia involving the cervical muscles and without mutations in the TOR1A (DYT1) gene or any other movement
disorders were recruited at a movement disorders clinic between June 2008 and June 2009. All the patients underwent clinical examination and were screened for
mutations of the THAP1 gene.
Results: Three patients had the novel p.Gln97Ter THAP1 nonsense mutation in heterozygosis. One of them had no family history of dystonia. Symptoms in this
patient first appeared in his right arm, and the condition progressed to the generalized form. The other two patients belonged to the same family (cousins).
Symptoms in the first patient started in her right arm at the age of 18 years and the condition progressed to the segmental form. The second patient, who carried the
p.Arg169Gln missense mutation, developed dystonia in her left arm at the age of 6 years. The condition progressed to generalized dystonia.
Discussion: We conclude that THAP1 mutations are also a cause, albeit uncommon, of segmental and generalized dystonia in the Brazilian population.
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Introduction
Over the past 20 years, several mutant genes (from DYT1 to DYT25)
have been identified in patients with pure forms of dystonia, dystonia
combined with other movement disorders, or sporadic dystonia. Until
the recent description of an association of the CIZ1 (DYT23), ANO-3
(DYT24), and GNAL (DYT25) genes in families with dystonia, only the
TOR1A (DYT1) and THAP1 (thanatos-associated protein domain-
containing, apoptosis-associated protein 1) (DYT6) genes had been
linked to primary dystonia.1 THAP1 is inherited in an autosomal
dominant fashion with penetrance ranging from 40% to 60%.2 The
onset of clinical features commonly occurs during childhood or
adolescence.2,3
THAP1, a causative gene for DYT6 dystonia, contains three exons
that encode a 213-amino acid THAP domain-containing protein
that is considered to be involved in endothelial cell proliferation and
proapoptotic processes and assumed to act as a transcription
factor.3–5 Extensive mutation analyses of the THAP1 gene by several
groups revealed more than 50 mutations, mainly concentrated in the
THAP domain.6 Reported clinical features of these mutations
include a segmental or generalized progressive dystonia that involves
mostly the upper limbs and craniocervical muscles. The phenotype is
highly variable, even within a single family, ranging from patients
who are asymptomatic to those with generalized dystonia.3,7,8 In the
present study, we report our findings of THAP1 mutations in a
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population of Brazilian patients with dystonia involving the cervical
region.
Methods
Subject selection and clinical assessment
Subjects with dystonia who attended the Botulinum Toxin and
Movement Disorders Outpatient Unit in the Neurology Service,
Hospital de Clı´nicas, UFPR, from June 2008 to June 2009 were
selected for the study. Two movement disorders specialists examined
all the patients (C.H.C. and H.A.T.). All the patients underwent brain
computed tomography (CT) and a cervical spine CT, and, depending
on the results of their clinical assessment, cervical spine magnetic
resonance imaging (MRI) and brain MRI as well as laboratory tests.
Seventy-four consecutive patients (48 females) presenting with isolated
dystonia affecting the cervical region (focal, segmental, multifocal, or
generalized) were included in the study. None of the patients had the
TOR1A (DYT1) mutation or any other movement disorder.
Mutation scanning of the THAP1 gene
DNA was extracted from peripheral blood leukocytes using the
Puregene DNA Isolation Kit (Gentra Systems Inc., Minneapolis, MN).
Amplifications were performed using GoTaqH Colorless Master Mix
(Promega, Madison, WI) in a final volume of 2.5 mL containing 100 ng
of genomic DNA and 10 pmol of each primer. Primers and
polymerase chain reaction conditions were as previously described,
and amplification was followed by sequencing.8
The study was approved by the local ethics committee (ref.
1676.093/2008-06).
Results
There were 19 familial cases (25.67%) in 13 families, and 55 cases
were sporadic. Focal cervical dystonia was observed in 33 patients
(44.59%), and 19 (25.67%) had segmental or multifocal dystonia.
Generalized dystonia was observed in 23 patients (31.1%). Mean age
at onset of the study population was 30.30¡20.97 years (range, 5
months to 72 years).
We found THAP1 mutations in two familial cases (A and B) and one
sporadic patient (C). These three patients had arm-onset dystonia,
which progressed to the segmental form in one patient and the
generalized form in two (Table 1). A novel nonsense mutation
c.289A.G (p.Gln97Ter) in exon 3 was found in heterozygosis in all
three patients (Figure 1). One familial case (B) with an additional
missense mutation (c.506G.A [p.Arg169Gln]) in exon 3 was a
compound heterozygote. SIFT (Sorting Intolerant From Tolerant)
analysis predicted this mutation to be tolerated and the other, p.GlnX,
to be deleterious. Both this patient’s parents were asymptomatic. The
father was a simple heterozygote for a novel nonsense mutation
c.289A.G (p.Gln97Ter). The mother, with no familial history, was a
simple heterozygote for the mutation c.506G.A (p.Arg169Gln).
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Discussion
The frequency of THAP1 mutations in dystonia cases in various
series in the literature varies from 0.6% to 4.7%, although it can reach
25% in a more specific population (onset before 22 years and a positive
familial history).9,10
Among our patients with THAP1 mutations, two were from the
same family (A and B) and one was sporadic (C). All three had early-
onset dystonia, which started in the arms and spread in a cranial–
cervical direction, progressing to the generalized form in two of the
three cases. In most DYT6 patients, dystonia starts in the arms or
Figure 1. Pedigrees of the Families with Patients with THAP1Mutations. (A) Sequencing analysis of the THAP1 gene showing the c.289A.G (p.Gln97Ter)
mutation in proband III-11 and her father (II-9). (B) Sequencing analysis of the THAP1 gene showing the c.506G.A (p.Arg169Gln) mutation in proband III-11 and her
mother (II-10).
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cranial–cervical region and progresses to generalized or segmental
dystonia.3,6–10 When the focal form is observed in these patients, late
onset is more common.8,9 In the literature, approximately 40% of
cases of dystonia do not have a familial history of the condition.6
We found a novel nonsense mutation (p.Gln97Ter) in a proline-rich
region where few mutations have been described.7–10 Despite this
difference, the phenotypes of the patients in this study were very
similar to those of most patients with mutations in other regions of the
THAP1 gene described in the literature.6–10 We also found a missense
mutation (p.Arg169Gln) in a familial compound heterozygote with the
p.Gln97Ter mutation. Onset was earlier than in the other patient from
the same family, and the dystonia progressed to a generalized form.
We speculate that more severe manifestations may be explained by
an additive effect of two compound heterozygous mutations. The
p.Arg169Gln mutation has been described before in an early-onset
familial case.7 A prediction based on in silico analysis resulted in a
possible deleterious effect (PolyPhen2), although using SIFT the amino
acid substitution was predicted to be tolerated. While some homo-
zygous mutations in the THAP1 gene have been described, this is, to
our knowledge, the first report of compound heterozygous muta-
tions.7,9–12 The novel nonsense mutation p.Gln97Ter is predicted to
be deleterious because the premature termination codon is in a
position that allows it to escape the nonsense-mediated mRNA decay
pathway. Consequently, an aberrant truncated protein is expected to
be generated.13
In the family with DYT6 dystonia (Figure 1), a significant
variability in the phenotype can be observed. The grandmother
possibly had a history of a late-onset speech disorder, an important
feature of the DYT6 phenotype.6–8 The parents of both probands
were asymptomatic. The age of onset was different for both
individuals, and in one of them the condition had not progressed
beyond the segmental form at the time of writing, while in the other
it progressed to the generalized form. Mutations in the THAP
domain have been associated with an earlier age of onset of dystonia
and with a more extensive anatomical distribution.14 However,
several studies indicate that there is little evidence to date of any
correlation between phenotype and genotype.15 Low penetrance
may explain sporadic cases, including a case in our study (C). This
heterogeneity of phenotypes and the asymptomatic patients could be
explained by the low penetrance (about 60%) and variable
expression of the THAP1 gene.2,6–8 Hence, additional genetic and
environmental factors may affect disease manifestation and the
severity of symptoms.
In agreement with previous studies, we suggest that analysis of the
DYT6 (THAP1) gene should be performed in patients with dystonia
involving the cervical region, regardless of the anatomical distribution
of the disease or the familial history. We conclude that THAP1
mutations are also a cause of segmental and generalized dystonia in the
Brazilian population.
References
1. Lohmann K, Klein C. Genetics of dystonia: What’s known? What’s new? What’s
next? Mov Disord 2013;28:899–905, doi: http://dx.doi.org/10.1002/mds.25536.
2. Saunders-Pullman R, Raymond D, Senthil G, et al. Narrowing the DYT6
dystonia region and evidence for locus heterogeneity in the Amish-Mennonites.
Am J Med Genet A 2007;143A:2098–2105, doi: http://dx.doi.org/10.1002/
ajmg.a.31887.
3. Fuchs T, Gavarini S, Saunders-Pullman R, et al. Mutations in the THAP1
gene are responsible for DYT6 primary torsion dystonia. Nat Genet 2009;41:
286–288, doi: http://dx.doi.org/10.1038/ng.304.
4. Roussigne M, Cayrol C, Clouaire T, Amalric F, Girard JP. THAP1 is a
nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to
PML nuclear bodies. Oncogene 2003;22:2432–2442, doi: http://dx.doi.org/10.
1038/sj.onc.1206271.
5. Kaiser FJ, Osmanoric A, Rakovic A, et al. The dystonia gene DYT1 is
repressed by the transcription factor THAP1 (DYT6). Ann Neurol 2010;68:554–
559, doi: http://dx.doi.org/10.1002/ana.22157.
6. Blanchard A, Ea V, Roubertie A, et al. DYT6 dystonia: Review of the
literature and creation of the UMD Locus-Specific Database (LSDB) for
mutations in the THAP1 gene. Hum Mutat 2011;32:1213–1224, doi: http://dx.
doi.org/10.1002/humu.21564.
7. Houlden H, Schneider SA, Paudel R, et al. THAP1 mutations (DYT6) are
an additional cause of early-onset dystonia. Neurology 2010;74:846–850, doi:
http://dx.doi.org/10.1212/WNL.0b013e3181d5276d.
8. Xiao J, Zhao Y, Bastian RW, et al. Novel THAP1 sequence variants in
primary dystonia. Neurology 2010;74:229–238, doi: http://dx.doi.org/10.1212/
WNL.0b013e3181ca00ca.
9. Bressman SB, Raymond D, Fuchs T, Heiman GA, Ozelius LJ, Saunders-
Pullman R. Mutations in THAP1 (DYT6) in early-onset dystonia: A genetic
screening study. Lancet Neurol 2009;8:441–446, doi: http://dx.doi.org/10.1016/
S1474-4422(09)70081-X.
10. Dobricˇic´ VS, Kresojevic´ ND, Svetel MV, et al. Mutation screening of the
DYT6/THAP1 gene in Serbian patients with primary dystonia. J Neurol 2013;
260:1037–1042, doi: http://dx.doi.org/10.1007/s00415-012-6753-6.
11. So¨hn AS, Glo¨ckle N, Doetzer AD, et al. Prevalence of THAP1 sequence
variants in German patients with primary dystonia. Mov Disord 2010;25:1982–
1986, doi: http://dx.doi.org/10.1002/mds.23207.
12. Schneider SA, Ramirez A, Shafiee K, et al. Homozygous THAP1
mutations as cause of early-onset generalized dystonia. Mov Disord 2011;26:858–
861, doi: http://dx.doi.org/10.1002/mds.23561.
13. Khajavi M, Inoue K, Lupski JR. Nonsense-mediated mRNA decay
modulates clinical outcome of genetic disease. Eur J Human Genet 2006;14:1074–
1081, doi: http://dx.doi.org/10.1038/sj.ejhg.5201649.
14. LeDoux MS1, Xiao J, Rudzin´ska M, et al. Genotype-phenotype
correlations in THAP1 dystonia: Molecular foundations and description of
new cases. Parkinsonism Relat Disord 2012;18:414–425, doi: http://dx.doi.org/10.
1016/j.parkreldis.2012.02.001.
15. Xiromerisiou G, Houlden H, Scarmeas N, et al. THAP1 mutations and
dystonia phenotypes: Genotype phenotype correlations. Mov Disord 2012;27:
1290–1294, doi: http://dx.doi.org/10.1002/mds.25146.
Camargo CHF, Camargos ST, Raskin S, et al. DYT6 in Brazilian Patients
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org
The Center for Digital Research and Scholarship
Columbia University Libraries/Information Services4
